Dorothy J. Park MD
Breast Cancer, Hematologic Oncology
Assistant Professor, Medicine, UCLA School of Medicine
Join to View Full Profile
9090 Wilshire BlvdSte 200Beverly Hills, CA 90211
Phone+1 310-888-8680
Fax+1 310-888-1886
Dr. Park is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Cedars-Sinai Medical CenterFellowship, Hematology and Medical Oncology, 1992 - 1994
UCLA-VA Greater Los AngelesResidency, Internal Medicine, 1987 - 1990
David Geffen School of Medicine at UCLAClass of 1987
Certifications & Licensure
CA State Medical License 1989 - 2026
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ARIA Radiation Oncology EMR, Varian Medical Systems, 2013
Clinical Trials
- Breast Cancer Study of Preoperative Pembrolizumab + Radiation Start of enrollment: 2017 Dec 22
Publications & Presentations
PubMed
- 5 citationsA phase Ib trial of pembrolizumab plus paclitaxel or flat-dose capecitabine in 1st/2nd line metastatic triple-negative breast cancer.David B Page, Joanna Pucilowska, Brie Chun, Isaac Kim, Katherine Sanchez
NPJ Breast Cancer. 2023-06-21 - 3 citationsScleroderma in a Patient on Capecitabine: Is this a Variant of Hand-Foot Syndrome?Muhammad Wasif Saif, Archana Agarwal, James Hellinger, Dorothy J. Park, Elizabeth R. Volkmann
Cureus. 2016-06-30 - 61 citationsA Phase Ib Study of AMG 102 in Combination with Bevacizumab or Motesanib in Patients with Advanced Solid TumorsPeter Rosen, Christopher Sweeney, Dorothy J. Park, Darrin M. Beaupre, Hongjie Deng
Clinical Cancer Research. 2010-05-01
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
